Identity
- Trade Name
- INNO-LiPA HCV 2.0 Control FDA UDI
- Generic Name
- Hepatitis C virus genotyping IVD, control FDA UDI
- Model / Reference
- 81661 FDA UDI
Identifiers
- Primary DI / UDI-DI
- 05414470816613 FDA UDI
- PMA Number
- P160016 FDA UDI
- FDA Product Code
- OBF FDA UDI
- GMDN Term
- Hepatitis C virus genotyping IVD, control FDA UDI
Classification
- Device Class
- Class II FDA UDI
- Regulation Number
- 866.3170 FDA UDI
- Commercial Distribution
- Not in Commercial Distribution FDA UDI
Clinical & Handling
Sterile
No
FDA UDI
Single Use
No
FDA UDI
Implantable
No
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
Yes
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
Yes
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
No
FDA UDI
Lot / Batch Number
Yes
FDA UDI
Serial Number
No
FDA UDI
Expiration Date
Yes
FDA UDI
Manufacturing Date
No
FDA UDI
INNO-LiPA HCV 2.0 Control by Fujirebio Europe — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS
Cleared under the same submission
P160016 also covers:
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | Class II | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Fujirebio Europe
Sources (1)
- FDA UDI 02871a9f-a0d3-4242-a5e1-d26c7e5eb1a7 37 fields · synced Jun 8, 2026